Pfizer Inc

Holdings as of Dec 31, 2025 · filed Feb 12, 2026

$236464562
Portfolio value
18
Positions
Source: SEC 13-F ↗
Original filing
# Holding Value % Port. Δ Shares Change (QoQ)
1 Oric Pharmaceuticals Inc $43978494 18.60% Held
2 Arvinas Inc $41009686 17.34% Held
3 Celcuity Inc $34849754 14.74% Held
4 Wave Life Sciences Ltd $31875000 13.48% Held
5 Allogene Therapeutics Inc $30183895 12.76% Held
6 Zura Bio Ltd $15562915 6.58% Held
7 Pyxis Oncology Inc $8087685 3.42% Held
8 Caribou Biosciences Inc $7457785 3.15% Held
9 Cardiff Oncology Inc $6776526 2.87% Held
10 Biohaven Ltd $5708732 2.41% Held
11 Spero Therapeutics Inc $5504271 2.33% Held
12 Nextcure Inc $2236997 0.95% Held
13 Zentalis Pharmaceuticals Inc $1287675 0.54% Held
14 Q32 Bio Inc $922220 0.39% Held
15 An2 Therapeutics Inc $815436 0.34% Held
16 Bolt Biotherapeutics Inc $171176 0.07% Held
17 Ginkgo Bioworks Holdings Inc $24332 0.01% Held
18 Senseonics Hldgs Inc $11983 0.01% -41255 -95.00%

Closed last quarter

Biontech Se Tourmaline Bio Inc Essa Pharma Inc

Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.